help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on January 17, 2008
Endocrinology, doi:10.1210/en.2007-1568
A more recent version of this article appeared on May 1, 2008
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
149/5/2261    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gashaw, I.
Right arrow Articles by Winterhager, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gashaw, I.
Right arrow Articles by Winterhager, E.

Submitted on November 13, 2007
Accepted on January 7, 2008

Pre-menstrual regulation of the pro-angiogenic factor CYR61 in human endometrium

Isabella Gashaw*, Simone Stiller, Carsten Böing, Rainer Kimmig, and Elke Winterhager

Institute of Anatomy, University of Duisburg-Essen, Essen, Germany; Department of Obstetrics and Gynaecology, University of Duisburg-Essen, Essen, Germany

* To whom correspondence should be addressed. E-mail: isabella.gashaw{at}uk-essen.de.

The pro-angiogenic factor CYR61 (CCN1) mediates different signals in tumorigenesis, angiogenesis and is involved in the pathogenesis of endometriosis. In this study, we investigated the temporal and spatial expression pattern in human endometrium during the menstrual cycle and its possible regulation mechanisms in the pre-menstrual phase. CYR61 transcript expression showed two distinct periods of elevated levels in the proliferative phase and in menstrual effluents. Since the menstrual breakdown of the functionalis is triggered by cytokines, prostaglandins as well as hypoxia, we employed a benign endometrial cell line to investigate if CYR61 is regulated by these factors. Hypoxic conditions transiently induced CYR61 mRNA levels and enhanced the secretion of the CYR61 protein into the medium. The hypoxia inducible factor HIF1{alpha} mediated this effect on CYR61 as evidenced by dimethyloxalylglycine treatment and by HIF1{alpha} siRNA. CYR61 mRNA expression was further regulated by IL1, TNF{alpha}, PGE2 and PGF2{alpha}. In addition, TNF{alpha} and PGE2 elevated significantly CYR61 cellular protein levels in well oxygenated cells but had only a slight effect on the quantity of secreted protein. Moreover, PGE2 combined with hypoxic conditions increased CYR61 mRNA and protein levels synergistically whereas the combination with TNF{alpha} abolished the CYR61 levels induced by hypoxia.

Taken together the upregulation of CYR61 by hypoxia via HIF1{alpha}, TNF{alpha} and PGE2 could represent possible mechanisms for the CYR61 increase at the onset of menstruation. The opposite effect of TNF{alpha} combined with hypoxia on CYR61 upregulation could contribute to a balanced expression level of this angiogenic factor in the endometrium.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society